ERBB2 and invasive breast carcinoma: The HER2 gene encodes an orphan receptor [75] with tyrosine kinase activity that is overexpressed in 30% of primary BrCa [76] usually correlating with enhanced tumor aggressiveness, lymph node metastasis and poor prognosis.